Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Dec;70(6):1198–1202. doi: 10.1038/bjc.1994.473

Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia.

D Trerè 1, A Pession 1, G Basso 1, R Rondelli 1, G Masera 1, G Paolucci 1, M Derenzini 1
PMCID: PMC2033703  PMID: 7981077

Abstract

Cell proliferation rate is a well-established prognostic factor in cancer, but it has not been considered to identify the risk group of childhood acute lymphoblastic leukaemia (ALL) at presentation. We carried out a study to demonstrate the prognostic importance of the rapidity of cell proliferation in patients with ALL. To measure the rapidity of cell proliferation we used the parameter relative to the area of silver-stained nucleolar organiser regions (AgNORs) as evaluated by morphometric analysis on smeared marrow blast cells. The mean AgNOR area of leukaemic marrow cells was measured in 119 children. By using a cut-off value of 3 microns2, we identified a group of 91 children with low proliferating blast activity (mean AgNOR value 2.11 microns2) and a group of 28 children with high proliferating activity (mean AgNOR value 3.29 microns2). The group of patients with a mean AgNOR value > 3 microns2 was characterised by a higher number of deaths, more frequent relapse and shorter time interval to relapse than the group of patients with mean AgNOR value < 3 microns2 (P < 0.01). Multivariate analysis performed to include T-cell immunophenotype, FAB morphology, leucocyte count and presence of mediastinal mass showed that the mean AgNOR value was the only independent predictor of unfavourable event-free survival probability (P > 0.01). Our results indicate that the rapidity of marrow blast cell proliferation is an important prognostic parameter in childhood ALL and should be routinely introduced in the group risk definition.

Full text

PDF
1198

Images in this article

1199Figure 1
on p.1199
1199Figure 2
on p.1199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basso G., Putti M. C., Cantú-Rajnoldi A., Saitta M., Santostasi T., Santoro N., Lippi A., Comelli A., Felici L., Favre C. The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP). Br J Haematol. 1992 Jun;81(2):184–191. doi: 10.1111/j.1365-2141.1992.tb08205.x. [DOI] [PubMed] [Google Scholar]
  2. Champlin R., Gale R. P. Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood. 1989 Jun;73(8):2051–2066. [PubMed] [Google Scholar]
  3. Crocker J., Macartney J. C., Smith P. J. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J Pathol. 1988 Feb;154(2):151–156. doi: 10.1002/path.1711540207. [DOI] [PubMed] [Google Scholar]
  4. Crocker J. Nucleolar organiser regions. Curr Top Pathol. 1990;82:91–149. doi: 10.1007/978-3-642-74668-0_3. [DOI] [PubMed] [Google Scholar]
  5. Derenzini M., Pession A., Farabegoli F., Trerè D., Badiali M., Dehan P. Relationship between interphasic nucleolar organizer regions and growth rate in two neuroblastoma cell lines. Am J Pathol. 1989 Apr;134(4):925–932. [PMC free article] [PubMed] [Google Scholar]
  6. Derenzini M., Pession A., Trerè D. Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest. 1990 Jul;63(1):137–140. [PubMed] [Google Scholar]
  7. Derenzini M., Ploton D. Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol. 1991;32:149–192. doi: 10.1016/b978-0-12-364932-4.50008-3. [DOI] [PubMed] [Google Scholar]
  8. Derenzini M., Trerè D. Importance of interphase nucleolar organizer regions in tumor pathology. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61(1):1–8. doi: 10.1007/BF02890399. [DOI] [PubMed] [Google Scholar]
  9. Dolbeare F., Gratzner H., Pallavicini M. G., Gray J. W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5573–5577. doi: 10.1073/pnas.80.18.5573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dow L. W., Chang L. J., Tsiatis A. A., Melvin S. L., Bowman W. P. Relationship of pretreatment lymphoblast proliferative activity and prognosis in 97 children with acute lymphoblastic leukemia. Blood. 1982 Jun;59(6):1197–1202. [PubMed] [Google Scholar]
  11. Goessens G. Nucleolar structure. Int Rev Cytol. 1984;87:107–158. doi: 10.1016/s0074-7696(08)62441-9. [DOI] [PubMed] [Google Scholar]
  12. Hara A., Niikawa S., Hirayama H., Sakai N., Yamada H., Ohno T., Tanaka T., Mori H. Correlation between nucleolar organizer region score and bromodeoxyuridine labeling index in C6 glioma cell line. J Neurooncol. 1991 Oct;11(2):149–155. doi: 10.1007/BF02390174. [DOI] [PubMed] [Google Scholar]
  13. Hoelzer D., Thiel E., Löffler H., Büchner T., Ganser A., Heil G., Koch P., Freund M., Diedrich H., Rühl H. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988 Jan;71(1):123–131. [PubMed] [Google Scholar]
  14. Murphy S. B., Aur R. J., Simone J. V., George S., Mauer A. M. Pretreatment cytokinetic studies in 94 children with acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment. Blood. 1977 May;49(5):683–691. [PubMed] [Google Scholar]
  15. Nakamura S., Takeda Y., Kanno M., Yoshida T., Ohtake S., Kobayashi K., Okabe Y., Matsuda T. Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the in vivo analysis of proliferative characteristics of human leukemia cells in bone marrows. Oncology. 1991;48(4):285–289. doi: 10.1159/000226944. [DOI] [PubMed] [Google Scholar]
  16. Ofner D., Hittmair A., Marth C., Ofner C., Tötsch M., Daxenbichler G., Mikuz G., Margreiter R., Schmid K. W. Relationship between quantity of silver stained nucleolar organizer regions associated proteins (Ag-NORs) and population doubling time in ten breast cancer cell lines. Pathol Res Pract. 1992 Aug;188(6):742–746. doi: 10.1016/S0344-0338(11)80171-8. [DOI] [PubMed] [Google Scholar]
  17. Orita T., Kajiwara K., Nishizaki T., Ikeda N., Kamiryo T., Aoki H. Nucleolar organizer regions in meningioma. Neurosurgery. 1990 Jan;26(1):43–46. doi: 10.1097/00006123-199001000-00006. [DOI] [PubMed] [Google Scholar]
  18. Pession A., Farabegoli F., Treré D., Novello F., Montanaro L., Sperti S., Rambelli F., Derenzini M. The Ag-NOR proteins and transcription and duplication of ribosomal genes in mammalian cell nucleoli. Chromosoma. 1991 May;100(4):242–250. doi: 10.1007/BF00344158. [DOI] [PubMed] [Google Scholar]
  19. Pileri S., Sabattini E., Tazzari P. L., Gherlinzoni F., Zucchini L., Bigerna B., Leoncini L., Rosso R., Stein H., Falini B. Hodgkin's disease: update of findings. Haematologica. 1991 May-Jun;76(3):175–182. [PubMed] [Google Scholar]
  20. Ploton D., Menager M., Jeannesson P., Himber G., Pigeon F., Adnet J. J. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J. 1986 Jan;18(1):5–14. doi: 10.1007/BF01676192. [DOI] [PubMed] [Google Scholar]
  21. Scarffe J. H., Hann I. M., Evans D. I., Morris Jones P., Palmer M. K., Lilleyman J. S., Crowther D. Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood. Br J Cancer. 1980 May;41(5):764–771. doi: 10.1038/bjc.1980.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tanaka T., Takeuchi T., Nishikawa A., Takami T., Mori H. Nucleolar organizer regions in hepatocarcinogenesis induced by N-2-fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry. Jpn J Cancer Res. 1989 Nov;80(11):1047–1051. doi: 10.1111/j.1349-7006.1989.tb02257.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. The nucleolar organizer regions. Biol Cell. 1983;49(3):191–202. [PubMed] [Google Scholar]
  24. Trerè D., Farabegoli F., Cancellieri A., Ceccarelli C., Eusebi V., Derenzini M. AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining. J Pathol. 1991 Sep;165(1):53–59. doi: 10.1002/path.1711650109. [DOI] [PubMed] [Google Scholar]
  25. Trerè D., Pession A., Derenzini M. The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res. 1989 Sep;184(1):131–137. doi: 10.1016/0014-4827(89)90371-6. [DOI] [PubMed] [Google Scholar]
  26. van der Does-van den Berg A., Bartram C. R., Basso G., Benoit Y. C., Biondi A., Debatin K. M., Haas O. A., Harbott J., Kamps W. A., Köller U. Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. Med Pediatr Oncol. 1992;20(6):497–505. doi: 10.1002/mpo.2950200603. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES